Skip to main
VTR
VTR logo

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 13%
Buy 67%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Ventas has established a robust and diversified healthcare portfolio consisting of nearly 1,400 properties, encompassing various sectors such as senior housing, medical offices, and life sciences, which positions the company to capitalize on multiple growth avenues in a favorable healthcare market. The firm's geographic diversification, with significant exposure to mature healthcare systems in the U.S., Canada, and the U.K., allows for sustained operational stability and potential for expansion in regions with similar healthcare dynamics. Additionally, Ventas's strategic advantage lies in its ability to navigate competitive pressures in the healthcare real estate investment trust (REIT) sector, focusing on maintaining occupancy and optimizing capital recycling despite the competitive landscape and fluctuating supply dynamics.

Bears say

Ventas faces significant challenges that negatively influence its outlook, primarily due to potential reductions in Medicare and Medicaid reimbursements, which could adversely affect rent coverage ratios. Additionally, the company exhibits a concerning tenant concentration, as several tenants account for over 5% of revenue, heightening the risk of financial instability if reimbursement rates decline. Finally, the healthcare REIT sector, characterized by bond-like cash flows, is expected to underperform amid rising interest rates, while access to capital markets remains crucial for Ventas's growth.

Ventas (VTR) has been analyzed by 15 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 67% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 15 analysts, Ventas (VTR) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.